Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1994-09-13
1995-08-29
Warden, Jill
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530325, 514 12, 514 2, 930DIG821, 930DIG820, 930DIG800, C07K 14635
Patent
active
054461308
ABSTRACT:
Peptide derivatives of the following general formula (I): ##STR1## wherein AAA is deletion or Ser, BBB is deletion or Glu, CCC is deletion, Ile, Phe, Leu, cyclohexylalanine, D-alle or Lys substituted at the .epsilon.-position by C.sub.6 --C.sub.18 alkylcarbonyl group, DDD is Gly or Gln, EEE is Leu, Nle or Phe, FFF is Met, Leu or Nle, GGG is Ala, Ser Leu, Asn, Asp or Gln, HHH is Leu, Glu or Lys, III is His, Lys or Arg, JJJ is His, Lys or Arg, Xaa is Ala modified at the carboxy terminal with an amino group, provided that CCC and DDD may independently be modified at the amino terminal by C.sub.2 --C.sub.18 alkylcarbonyl group, and that EEE is not Leu when FFF is Met, GGG is Asn, HHH is Leu, III and JJJ are His, and the salts thereof, which exhibit a potent inhibitory activity against hPTH and are useful as a therapeutic agent for treating dysbolism associated with calcium or phosphoric acid, such as hypercalcemia, osteoporosis, hyperparathyroidism, renal osteodystrophy, and the like, and other related diseases involving PTH or PTHrP.
REFERENCES:
patent: 3886132 (1975-05-01), Brewer et al.
patent: 4423037 (1983-12-01), Rosenblatt et al.
patent: 4656250 (1987-04-01), Morita et al.
patent: 5229489 (1993-07-01), Kanmera et al.
Chemical Abstracts, vol. 105, No. 25, Dec. 22, 1986, C. Paul Bianchi.
Rosenblatt et al., Biochemistry, 20 7246-50 (1981).
McKee et al., Endocrinology, 127(1) 76-82 (1990).
Nutt et al., Endocrinology, 127(1) 491-93 (1990).
Horiuchi et al., Science, 238 1566-68 (1987).
Juppner et al., Biochemistry, 29(30) 6941-46 (1990).
Strewler et al., The Journal of Clinical Investigation, 80 1803-1807 (1987).
Donahue et al., Endocrinology, 126(3) 1471-77 (1990).
Goltzmann et al., The Journal of Biological Chemistry, 250(8) 3199-3203 (1975).
Cohen et al., The Journal of Biological Chemistry, 266(3) 1997-2004 (1991).
Moseley et al., Proc. Natl. Acad. Sci. USA, 84 5048-52 (1987).
Suva et al., Science, 327 893-896 (1987).
Coltrera et al., American Chemical Society, 19(18) 4380-4384 (1980).
Mangin et al., Proc. Natl. Acad. Sci. USA, 85 597-601 (1988).
Kanmera Tatsuhiko
Minegishi Toshihiko
Mori Akihisa
Nakao Yoshihide
Mitsubishi Kasei Corporation
Warden Jill
Wessendorf T. D.
LandOfFree
Parathyroid hormone antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parathyroid hormone antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parathyroid hormone antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1820141